XOMA Corporation (XOMA) Financial Statements (2024 and earlier)

Company Profile

Business Address 2200 POWELL STREET
EMERYVILLE, CA 94608
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments153,45158,16194,10284,22256,68845,780
Cash and cash equivalents153,29057,82693,32884,22256,68845,780
Short-term investments161335774   
Restricted cash and investments160 2,0491,611  
Receivables    1,5262,9331,468
Other undisclosed current assets15,7023,092822706352378
Total current assets:169,31361,25396,97388,06559,97347,626
Noncurrent Assets
Operating lease, right-of-use asset37829200359510
Property, plant and equipment25713213459
Intangible assets, net (including goodwill) 14,25315,150    
Intangible assets, net (excluding goodwill) 14,25315,150    
Restricted cash and investments6,100  531  
Other noncurrent assets53326030141151708
Other undisclosed noncurrent assets43,69963,68369,07536,26835,05615,392
Total noncurrent assets:64,98879,12969,58937,22035,75116,159
TOTAL ASSETS:234,301140,382166,562125,28595,72463,785
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,2721,9931,5531,0981,5592,029
Interest and dividends payable 4469 
Taxes payable91   
Employee-related liabilities55207563155
Accounts payable6535241,0724566141,244
Accrued liabilities2,6191,469335391313630
Deferred revenue2,1131,8991,6411,4521,894
Debt5,543  8,0885,347789
Contract with customer, liability798
Other undisclosed current liabilities8,5712,9269,7731,664752,087
Total current liabilities:19,4996,81812,96712,3028,8755,703
Noncurrent Liabilities
Long-term debt and lease obligation118,518 3412,99327,50121,690
Long-term debt, excluding current maturities118,518  12,76427,09321,690
Liabilities, other than long-term debt7,5639,55011,68513,56615,360590
Deferred revenue7,2289,55011,68513,51615,317
Other liabilities    5043590
Operating lease, liability335 34229408
Other undisclosed noncurrent liabilities      17,017
Total noncurrent liabilities:126,0819,55011,71926,55942,86139,297
Total liabilities:145,58016,36824,68638,86151,73645,000
Equity
Equity, attributable to parent, including:88,721124,014141,87686,42443,98818,785
Common stock868685847365
Additional paid in capital1,311,8091,306,2711,307,0301,267,3771,238,2991,211,122
Accumulated deficit(1,223,223)(1,182,392)(1,165,288)(1,181,086)(1,194,384)(1,192,402)
Other undisclosed equity, attributable to parent49494949  
Total equity:88,721124,014141,87686,42443,98818,785
TOTAL LIABILITIES AND EQUITY:234,301140,382166,562125,28595,72463,785

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues4,7586,02738,16029,38518,3705,299
Gross profit:4,7586,02738,16029,38518,3705,299
Operating expenses(46,606)(23,441)(20,631)(16,969)(22,255)(22,156)
Operating income (loss):(41,848)(17,414)17,52912,416(3,885)(16,857)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
1,586295(879)1,2253,8224,338
Interest and debt expense(569) (761)(1,844)(1,919)(922)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Income (loss) from continuing operations before income taxes:(40,831)(17,119)15,88911,797(1,982)(13,441)
Income tax expense (benefit)  15(91)1,501 98
Income (loss) from continuing operations:(40,831)(17,104)15,79813,298(1,982)(13,343)
Income (loss) before gain (loss) on sale of properties:15,79813,298(1,982)(13,343)
Net income (loss) attributable to parent:(40,831)(17,104)15,79813,298(1,982)(13,343)
Preferred stock dividends and other adjustments   (88)  
Undistributed earnings (loss) allocated to participating securities, basic   (3,451)(4,417)  
Other undisclosed net loss available to common stockholders, basic(5,472)(5,472)(4,560)   
Net income (loss) available to common stockholders, basic:(46,303)(22,576)7,7878,793(1,982)(13,343)
Other undisclosed net income available to common stockholders, diluted   181217  
Net income (loss) available to common stockholders, diluted:(46,303)(22,576)7,9689,010(1,982)(13,343)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(40,831)(17,104)15,79813,298(1,982)(13,343)
Comprehensive income (loss), net of tax, attributable to parent:(40,831)(17,104)15,79813,298(1,982)(13,343)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: